ICED Project Celebration

Last Wednesday, Fraser Health celebrated the successful launch of the Implantable Cardiac Electrical Devices (ICED) Project, a regional model to standardize the service and delivery of cardiac devices. The ICED celebration brought together various stakeholders, such as sponsors, surgical and cardiac representatives and Fraser Health CEO Dr. Nigel Murray. As a major contributor to the ICED project, Iridia founder, Dr. Allan Holmes was on hand as Master of Ceremony. In his role as the Hospital Medical Coordinator, Dr. Holmes worked with the ICED project as a senior physician leader and liaison for the site. He also provided expertise into the management of adverse events and coordinated a specialized ACLS training program for the implanter group.

ICED

ICED celebration cake

The vision

To have the BEST Implantable Cardiac Electrical Devices program in Canada

What did we do?

Implemented a regional model for Implantable Cardiac Electrical Devices

Why did we do it?

  • To enhance the quality of care provided to patients
  • To maximize operational efficiencies in order to meet or exceed recognized wait time standards
  • To standardize pre and post-procedure care in accordance with evidence informed practices
  • To improve timely and equitable access to service
  • To optimize existing capacity and provide for future growth
  • To enable ongoing surveillance and monitoring of the ICED program

How did we do it?

  • Consolidated from four sites (ERH, SMH, BH, RCH) to two regional sites (RCH & JPOCSC).
  • Centralized referral/booking and patient triaging processes
  • Standardized clinical practice support tools & inventory management processes

Learn more about the ICED Project 

Implantable Cardiac Devices Standardized Throughout Fraser Health

Effective September 2012, a regional model to standardize the service and delivery of Implantable Cardiac Electrical Devices (ICED) has been implemented throughout the Fraser Health Authority (FHA).

The purpose of the ICED project is to improve inpatient and outpatient access to device implants and replacement.

The types of Implantable Cardiac Devices included are:

  • Permanent pacemakers (PPM)
  • Implantable cardioverter defibrillators (ICD)
  • Cardiac resynchronization therapy (CRT) devices

Implantable Cardiac Devices

In his role as Hospital Medical Coordinator for the Jim Pattison Outpatient Care and Surgery Centre (JPOCSC), Dr. Holmes (founder of Iridia Medical) was involved with the ICED project by assisting and providing input into the project to the extent it impacted on physicians and/or service planning at the JPOCSC.

The team at Iridia Medical also contributed to revisions to the transport and admission protocols for the JPOCSC and other FHA facilities for patients receiving cardiac implants.

Presently, two hospitals have been designated as regional ICED sites:

  • Royal Columbian Hospital (RCH) – PPM, ICD and CRT devices
  • Jim Pattison Outpatient Care and Surgery Centre (JPOCSC) – PPM only

Royal Columbian and JPOCSC

The development of the ICED project has led to a variety of new clinical practice tools with the standing goal of improving device implants and replacement:

  • Regional referral form
  • Pre and post-procedure pre-printed physician orders
  • Inter-hospital transfer instructions and checklists, outpatient checklist and pamphlets
  • Patient and Family Information booklets

Current pacemaker practices were refined to align with the new regional model, such as the exclusion of an anaesthesiologist during PPM implantation for certain patients who meet defined criteria.

In lieu of an anaesthesiologist there will be trained personnel present during the procedure dedicated to monitoring the patient. In the future, this practice change will allow for PPMs to be implanted in procedure rooms other than operating rooms; allowing for more versatile use.

Dr. Holmes and Iridia applaud Fraser Heath for their excellent work developing the ICED project.